Compare · BDMD vs RMD
BDMD vs RMD
Side-by-side comparison of Baird Medical Investment Holdings Ltd (BDMD) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDMD and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $31.89B, about 686.8x BDMD ($46.4M).
- Over the past year, BDMD is down 54.8% and RMD is down 21.3% - RMD leads by 33.5 points.
- RMD has been more active in the news (7 items in the past 4 weeks vs 6 for BDMD).
- RMD has more recent analyst coverage (25 ratings vs 0 for BDMD).
- Company
- Baird Medical Investment Holdings Ltd
- ResMed Inc.
- Price
- $1.09-0.91%
- $219.80-0.57%
- Market cap
- $46.4M
- $31.89B
- 1M return
- -10.66%
- -0.11%
- 1Y return
- -54.77%
- -21.26%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 6
- 7
- Recent ratings
- 0
- 25
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest BDMD
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
- Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
- SEC Form 424B3 filed by Baird Medical Investment Holdings Ltd
- SEC Form EFFECT filed by Baird Medical Investment Holdings Ltd
- SEC Form EFFECT filed by Baird Medical Investment Holdings Ltd
- Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
- SEC Form POS AM filed by Baird Medical Investment Holdings Ltd
- Amendment: SEC Form F-3/A filed by Baird Medical Investment Holdings Ltd
- SEC Form SCHEDULE 13D filed by Baird Medical Investment Holdings Ltd
Latest RMD
- Director Farrell Peter C sold $227,688 worth of ResMed Common Stock (970 units at $234.73) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 51,803 units (SEC Form 4)
- SEC Form 8-K filed by ResMed Inc.
- Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
- 23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
- Rothschild & Co Redburn initiated coverage on ResMed with a new price target
- SEC Form 8-K filed by ResMed Inc.
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- SEC Form 10-K filed by ResMed Inc.
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,026,596 worth of ResMed Common Stock (4,991 units at $205.69) as part of a pre-agreed trading plan (SEC Form 4)
- ResMed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition